share_log

BTIG Maintains Buy on Acutus Medical, Lowers Price Target to $1.5

BTIG Maintains Buy on Acutus Medical, Lowers Price Target to $1.5

BTIG 维持对Acutus Medical的买入,将目标股价下调至1.5美元
Benzinga Real-time News ·  2022/06/24 09:20

BTIG analyst Marie Thibault maintains Acutus Medical (NASDAQ:AFIB) with a Buy and lowers the price target from $2 to $1.5.

BTIG分析师玛丽·蒂博维持Acutus Medical(纳斯达克股票代码:AFIB)的买入,并将目标股价从2美元下调至1.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发